221 related articles for article (PubMed ID: 24485160)
1. LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response.
Chirico V; Ferraù V; Loddo I; Briuglia S; Amorini M; Salpietro V; Lacquaniti A; Salpietro C; Arrigo T
Diabetes Metab; 2014 Jun; 40(3):224-8. PubMed ID: 24485160
[TBL] [Abstract][Full Text] [Related]
2. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
3. Monogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metformin.
Gambineri A; Semple RK; Forlani G; Genghini S; Grassi I; Hyden CS; Pagotto U; O'Rahilly S; Pasquali R
Eur J Endocrinol; 2008 Sep; 159(3):347-53. PubMed ID: 18728124
[TBL] [Abstract][Full Text] [Related]
4. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
Akinci B; Onay H; Demir T; Savas-Erdeve Ş; Gen R; Simsir IY; Keskin FE; Erturk MS; Uzum AK; Yaylali GF; Ozdemir NK; Atik T; Ozen S; Yurekli BS; Apaydin T; Altay C; Akinci G; Demir L; Comlekci A; Secil M; Oral EA
Metabolism; 2017 Jul; 72():109-119. PubMed ID: 28641778
[TBL] [Abstract][Full Text] [Related]
6. Familial partial lipodystrophy associated with the heterozygous LMNA mutation 1445G>A (Arg482Gln) in a Polish family.
Drac H; Madej-Pilarczyk A; Gospodarczyk-Szot K; Gaweł M; Kwieciński H; Hausmanowa-Petrusewicz I
Neurol Neurochir Pol; 2010; 44(3):291-6. PubMed ID: 20625965
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
[TBL] [Abstract][Full Text] [Related]
8. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism.
Vantyghem MC; Faivre-Defrance F; Marcelli-Tourvieille S; Fermon C; Evrard A; Bourdelle-Hego MF; Vigouroux C; Defebvre L; Delemer B; Wemeau JL
Clin Endocrinol (Oxf); 2007 Aug; 67(2):247-9. PubMed ID: 17524034
[TBL] [Abstract][Full Text] [Related]
9. Familial partial lipodystrophy as differential diagnosis of polycystic ovary syndrome.
Lewandowski KC; Lewiński A; Dąbrowska K; Jakubowski L; Gach A
Endokrynol Pol; 2015; 66(6):550-4. PubMed ID: 26662654
[TBL] [Abstract][Full Text] [Related]
10. Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl.
Krawiec P; Mełges B; Pac-Kożuchowska E; Mroczkowska-Juchkiewicz A; Czerska K
BMC Pediatr; 2016 Mar; 16():38. PubMed ID: 26976018
[TBL] [Abstract][Full Text] [Related]
11. Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report.
Collet-Gaudillat C; Billon-Bancel A; Beressi JP
Diabetes Metab; 2009 Apr; 35(2):151-4. PubMed ID: 19249234
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report.
Moreau F; Boullu-Sanchis S; Vigouroux C; Lucescu C; Lascols O; Sapin R; Ruimy D; Guerci B; Pinget M; Jeandidier N
Diabetes Metab; 2007 Nov; 33(5):385-9. PubMed ID: 17936664
[TBL] [Abstract][Full Text] [Related]
13. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
[TBL] [Abstract][Full Text] [Related]
14. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation.
Mory PB; Crispim F; Kasamatsu T; Gabbay MA; Dib SA; Moisés RS
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1252-6. PubMed ID: 19169477
[TBL] [Abstract][Full Text] [Related]
15. Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
Demir T; Onay H; Savage DB; Temeloglu E; Uzum AK; Kadioglu P; Altay C; Ozen S; Demir L; Cavdar U; Akinci B
Diabet Med; 2016 Oct; 33(10):1445-50. PubMed ID: 26756202
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics in two patients with partial lipodystrophy and Type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene.
Iwanishi M; Kusakabe T; Azuma C; Tezuka Y; Yamamoto Y; Ito-Kobayashi J; Washiyama M; Morimoto M; Ebihara K
Diabetes Res Clin Pract; 2019 Jun; 152():79-87. PubMed ID: 31102683
[TBL] [Abstract][Full Text] [Related]
17. Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA.
Thong KM; Xu Y; Cook J; Takou A; Wagner B; Kawar B; Ong AC
Nephron Clin Pract; 2013; 124(1-2):31-7. PubMed ID: 24080738
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects.
Gambineri A; Zanotti L
Nucleus; 2018; 9(1):392-397. PubMed ID: 30131000
[TBL] [Abstract][Full Text] [Related]
19. Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene - case study of three women from one family.
Nabrdalik K; Strózik A; Minkina-Pędras M; Jarosz-Chobot P; Młynarski W; Grzeszczak W; Gumprecht J
Endokrynol Pol; 2013; 64(4):306-11. PubMed ID: 24002959
[TBL] [Abstract][Full Text] [Related]
20. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
